Siegmund et al. reported that an increase of endogenous adenosine levels, via pharmacological blockade of adenosine kinase by the selective inhibitor GP515, ameliorates DSS-induced colitis blunting the proinflammatory cytokine synthesis as well as suppressing interferon (IFN)-γ in colonic tissue [57]. Here, IFNG is linked to colitis.